MRK vs ZTS
By Alex · Tickerpine
Merck & Co., Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | ZTS |
|---|---|---|
| Price | $145.27 | $81.03 |
| Market cap | $358.41B | $33.48B |
| P/E ratio | 117.2 | 13.5 |
| ROE | 6.96% | 64.91% |
| Profit margin | 4.77% | 27.68% |
| Revenue growth | 5.10% | -0.20% |
| Dividend yield | 2.34% | 2.62% |
| Beta | 0.22 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs ZTS in plain English
- MRK is the bigger company — about 10.7× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 13.5 vs 117.2).
- ZTS earns a higher return on equity (65% vs 7%).
- MRK is growing revenue faster (5% vs -0%).
- ZTS has the higher dividend yield (2.62% vs 2.34%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.